Pinnacle Wealth Planning Services’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
Other funds holding BIO
Pinnacle Wealth Planning Services's BIO Position: Q3 2026 in Review
Pinnacle Wealth Planning Services increased its Bio-Rad Laboratories Class A (BIO) stake by 3% in Q3 2026, buying an estimated $698 and bringing the position to 69 shares worth $26.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1651.
Pinnacle Wealth Planning Services first reported a position in BIO in Q4 2020 and has held it in 5 quarters since. The position peaked at $102K in Q4 2020. 419 funds tracked by Wall St. Rank hold BIO as of Q3 2026.
- Pinnacle Wealth Planning Services held 69 shares of Bio-Rad Laboratories Class A worth $26.1K as of Q3 2026.
- Pinnacle Wealth Planning Services bought 2 Bio-Rad Laboratories Class A shares in Q3 2026, an estimated $698.
- Bio-Rad Laboratories Class A made up ﹤0.01% of Pinnacle Wealth Planning Services's portfolio in Q3 2026, its #1651 holding.
- Pinnacle Wealth Planning Services first reported a position in Bio-Rad Laboratories Class A in Q4 2020 and has held it in 5 quarters since.
- Pinnacle Wealth Planning Services's Bio-Rad Laboratories Class A position peaked at $102K in Q4 2020.
- 419 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2026.
Based on Pinnacle Wealth Planning Services's 13F filing for Q3 2026, filed 27 Oct 2026.